Cite
HARVARD Citation
Tanaka, T. et al. (2022). Effect of upfront combination therapy on the overall survival of patients with metastatic castration‐sensitive prostate cancer: A multicenter retrospective study. International journal of urology. pp. 476-478. [Online].